Join Growin Stock Community!

Polyrizon ltd.PLRZ.US Overview

US StockHealthcare
(No presentation for PLRZ)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

PLRZ AI Insights

PLRZ Overall Performance

PLRZ AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

PLRZ Recent Performance

-1.08%

Polyrizon ltd.

0.05%

Avg of Sector

-0.31%

S&P500

PLRZ PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

PLRZ Key Information

PLRZ Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

PLRZ Profile

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.

Price of PLRZ

PLRZ FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

PLRZ Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.84
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
0.75
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
-%
Net Margin
-%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
100.00%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.84
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
0.75
Price-to-FCF
-
Gross Margin
-%
Net Margin
-%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
100.00%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%

  • When is PLRZ's latest earnings report released?

    The most recent financial report for Polyrizon ltd. (PLRZ) covers the period of 2024Q4 and was published on 2024/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating PLRZ's short-term business performance and financial health. For the latest updates on PLRZ's earnings releases, visit this page regularly.

  • How much cash does PLRZ have?

    At the end of the period, Polyrizon ltd. (PLRZ) held Total Cash and Cash Equivalents of 15.83M, accounting for 0.84 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Is PLRZ's EPS continuing to grow?

    According to the past four quarterly reports, Polyrizon ltd. (PLRZ)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -0.23. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What are the PEG ratio and PE ratio of PLRZ?

    The latest valuation data shows Polyrizon ltd. (PLRZ) has a Price-To-Earnings (PE) ratio of -2.04 and a Price/Earnings-To-Growth (PEG) ratio of -9.25. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.